Marketing

  " Artificial Intelligence (AI)-based Clinical Trials Market Summary: According to the latest report published by Data Bridge Market Research,  the  Artificial Intelligence (AI)-based Clinical Trials Market Data Bridge Market Research analyses that the artificial intelligence (AI)-based clinical trials market which was USD 1.3 billion in 2021, would rocket up to USD 5.55 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. DBMR team is focused on understanding client’s business and their needs so that the finest Artificial Intelligence (AI)-based Clinical Trials Market research report i...

  " Global Executive Summary  Artificial Intelligence (AI)-based Clinical Trials Market : Size, Share, and Forecast Data Bridge Market Research analyses that the artificial intelligence (AI)-based clinical trials market which was USD 1.3 billion in 2021, would rocket up to USD 5.55 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. The complete Artificial Intelligence (AI)-based Clinical Trials Market report is spread across a number of pages, list of tables & figures, profiling many companies. The major topics of this document can be listed as overview of Artificial Intelligence (AI)-based ...

  Artificial Intelligence (AI)-Based Clinical Trials Market 1. Introduction The  Artificial Intelligence (AI)-based Clinical Trials Market  is rapidly transforming the global healthcare and pharmaceutical landscape. By integrating advanced technologies such as machine learning, natural language processing, predictive analytics, and automation, AI is reshaping how clinical trials are designed, conducted, and monitored. Traditionally, clinical trials have been time-consuming, costly, and complex. However, AI-driven solutions are improving efficiency, accelerating drug development timelines, and enhancing patient outcomes. The importance of this market has grown significantly in the global economy, particularly as pharmaceutical companies seek faster and more cost-effective ways to bring innovative therapies to market. The rising burden of chronic diseases, increasing demand for personalized medicine, and growing investments in healthcare technology are driving the adoption ...